Pauric Bannigan, Intrepid Labs' explains where AI speeds formulation decisions, why data is the bottleneck, and how active learning trains models with far less data.
News|Articles|October 27, 2026
Beyond Triton X-100: Evaluating Viral Inactivation Strategies for Modern Bioprocessing
Author(s)Avantor
As Triton X-100 faces growing regulatory and sustainability challenges, biopharmaceutical manufacturers are evaluating alternatives for detergent-based viral inactivation. This whitepaper examines key considerations for replacing Triton X-100, including viral clearance, product quality, process compatibility, residual clearance, and implementation, while sharing data on J.T.Baker® Viral Inactivation Solution.
Related to this article
The new initiative aims to apply traceable AI and science to expand care worldwide by translating discovery into tools that accelerate drug development.
Sanjay Konagurthu, PhD, senior director, Science and Innovation at Thermo Fisher Scientific, provides an update on the progress of AI and machine learning used in drug delivery.
Stephanie Johnson, Pfizer, explains how off-platform triggers, single-owner risk registers, and traceable prior knowledge keep protein formulation programs on track.
Stephanie Johnson, Pfizer, discusses how platform formulations moved 2 Pfizer protein programs to IND in 8 months by redistributing, not removing risk.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
3
Manufacturing Intelligence: How AI Poisoning Hides in Plain Sight
4
Pfizer's 8-Month Path from Candidate to IND: AAPS PharmSci 360 2026
5